The effect of nano-curcumin on HbA1c, fasting blood glucose, and lipid profile in diabetic subjects: a randomized clinical trial

OBJECTIVE: Diabetes mellitus is defined as a group of metabolic diseases characterized by hyperglycemia resulting from defects in insulin secretion, insulin action, or both or insulin resistance. Curcumin inhibits NF-κB signaling pathway. The aim of this study is evaluation of the effect of Nano-cur...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahimi, Hamid Reza, Mohammadpour, Amir Hooshang, Dastani, Mostafa, Jaafari, Mahmoud Reza, Abnous, Khalil, Ghayour Mobarhan, Majid, Kazemi Oskuee, Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mashhad University of Medical Sciences 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052420/
https://www.ncbi.nlm.nih.gov/pubmed/27761427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052420/
https://www.ncbi.nlm.nih.gov/pubmed/27761427

Ejemplares similares